430 related articles for article (PubMed ID: 19196800)
41. Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes.
Rodriguez AM; Perron B; Lacroix L; Caillou B; Leblanc G; Schlumberger M; Bidart JM; Pourcher T
J Clin Endocrinol Metab; 2002 Jul; 87(7):3500-3. PubMed ID: 12107270
[TBL] [Abstract][Full Text] [Related]
42. Dietary I(-) absorption: expression and regulation of the Na(+)/I(-) symporter in the intestine.
Nicola JP; Carrasco N; Masini-Repiso AM
Vitam Horm; 2015; 98():1-31. PubMed ID: 25817864
[TBL] [Abstract][Full Text] [Related]
43. The sodium iodide symporter: its pathophysiological and therapeutic implications.
Spitzweg C; Morris JC
Clin Endocrinol (Oxf); 2002 Nov; 57(5):559-74. PubMed ID: 12390328
[TBL] [Abstract][Full Text] [Related]
44. An Intramolecular Ionic Interaction Linking Defective Sodium/Iodide Symporter Transport to the Plasma Membrane and Dyshormonogenic Congenital Hypothyroidism.
Bernal Barquero CE; Martín M; Geysels RC; Peyret V; Papendieck P; Masini-Repiso AM; Chiesa AE; Nicola JP
Thyroid; 2022 Jan; 32(1):19-27. PubMed ID: 34726525
[No Abstract] [Full Text] [Related]
45. Dietary flavonoids and iodine metabolism.
Schröder-van der Elst JP; Smit JW; Romijn HA; van der Heide D
Biofactors; 2003; 19(3-4):171-6. PubMed ID: 14757968
[TBL] [Abstract][Full Text] [Related]
46. The Iodide Transport Defect-Causing Y348D Mutation in the Na
Reyna-Neyra A; Jung L; Chakrabarti M; Suárez MX; Amzel LM; Carrasco N
Thyroid; 2021 Aug; 31(8):1272-1281. PubMed ID: 33779310
[No Abstract] [Full Text] [Related]
47. The sodium/iodide symporter: state of the art of its molecular characterization.
Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430
[TBL] [Abstract][Full Text] [Related]
48. Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond.
Dohán O; Carrasco N
Mol Cell Endocrinol; 2003 Dec; 213(1):59-70. PubMed ID: 15062574
[TBL] [Abstract][Full Text] [Related]
49. Differential regulation of apical and basal iodide transporters in the thyroid by thyroglobulin.
Suzuki K; Kohn LD
J Endocrinol; 2006 May; 189(2):247-55. PubMed ID: 16648292
[TBL] [Abstract][Full Text] [Related]
50. Na(+)/I(-) symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues.
Lacroix L; Mian C; Caillou B; Talbot M; Filetti S; Schlumberger M; Bidart JM
Eur J Endocrinol; 2001 Mar; 144(3):297-302. PubMed ID: 11248751
[TBL] [Abstract][Full Text] [Related]
51. The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.
Ravera S; Reyna-Neyra A; Ferrandino G; Amzel LM; Carrasco N
Annu Rev Physiol; 2017 Feb; 79():261-289. PubMed ID: 28192058
[TBL] [Abstract][Full Text] [Related]
52. Regulation of thyroid sodium-iodide symporter in different stages of goiter: Possible involvement of reactive oxygen species.
Matos LPL; Penha RCC; Cardoso-Weide LC; Freitas ML; Silva DLSG; Ferreira ACF
Clin Exp Pharmacol Physiol; 2018 Apr; 45(4):326-334. PubMed ID: 29112772
[TBL] [Abstract][Full Text] [Related]
53. The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance.
Dohán O; De la Vieja A; Paroder V; Riedel C; Artani M; Reed M; Ginter CS; Carrasco N
Endocr Rev; 2003 Feb; 24(1):48-77. PubMed ID: 12588808
[TBL] [Abstract][Full Text] [Related]
54. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.
De La Vieja A; Dohan O; Levy O; Carrasco N
Physiol Rev; 2000 Jul; 80(3):1083-105. PubMed ID: 10893432
[TBL] [Abstract][Full Text] [Related]
55. Congenital hypothyroidism due to a new deletion in the sodium/iodide symporter protein.
Tonacchera M; Agretti P; de Marco G; Elisei R; Perri A; Ambrogini E; De Servi M; Ceccarelli C; Viacava P; Refetoff S; Panunzi C; Bitti ML; Vitti P; Chiovato L; Pinchera A
Clin Endocrinol (Oxf); 2003 Oct; 59(4):500-6. PubMed ID: 14510914
[TBL] [Abstract][Full Text] [Related]
56. Regulation of solute carrier family 26 member 7 (Slc26a7) by thyroid stimulating hormone in thyrocytes.
Tanimura Y; Kiriya M; Kawashima A; Mori H; Luo Y; Kondo T; Suzuki K
Endocr J; 2021 Jun; 68(6):691-699. PubMed ID: 33583874
[TBL] [Abstract][Full Text] [Related]
57. [Sodium-iodine symporter in thyroid, normal and cancer tissues and its relation to nuclear medicine and to gene cloning treatment].
Foujilas C; Marakaki C; Syrmos N
Hell J Nucl Med; 2009; 12(2):189-93. PubMed ID: 19675882
[TBL] [Abstract][Full Text] [Related]
58. Characterization and semiquantitative analyses of pendrin expressed in normal and tumoral human thyroid tissues.
Porra V; Bernier-Valentin F; Trouttet-Masson S; Berger-Dutrieux N; Peix JL; Perrin A; Selmi-Ruby S; Rousset B
J Clin Endocrinol Metab; 2002 Apr; 87(4):1700-7. PubMed ID: 11932304
[TBL] [Abstract][Full Text] [Related]
59. Fluoride Exposure Induces Inhibition of Sodium/Iodide Symporter (NIS) Contributing to Impaired Iodine Absorption and Iodine Deficiency: Molecular Mechanisms of Inhibition and Implications for Public Health.
Waugh DT
Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30917615
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis of iodide transport defect: do we need to measure the saliva/serum radioactive iodide ratio to diagnose iodide transport defect?
Fukata S; Hishinuma A; Nakatake N; Tajiri J
Thyroid; 2010 Dec; 20(12):1419-21. PubMed ID: 21054210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
